Glucocorticoid Receptor, Nuclear Factor κB, Activator Protein-1 and C-Jun N-Terminal Kinase in Systemic Lupus Erythematosus Patients

Publisher： Karger

E-ISSN： 1423-0216|13|4|194-204

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.13, Iss.4, 2007-03, pp. : 194-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Antenatal Glucocorticosteroid Exposure on Osteoprotegerin and Receptor Activator of Nuclear Factor κB Ligand Levels in Newborn Infants

By  

Hormone Research in Paediatrics, Vol. 85, Iss. 4, 2016-03 ,pp. : 257-264

Karger

Access to resources Recommend Favorite

Nuclear Factor-ĸB- and Glucocorticoid Receptor α- Mediated Mechanisms in the Regulation of Systemic and Pulmonary Inflammation during Sepsis and Acute Respiratory Distress Syndrome

By  

Neuroimmunomodulation, Vol. 12, Iss. 6, 2012-01 ,pp. : 321-338

Karger

Access to resources Recommend Favorite

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite

Role of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Inteleukin-6 in Predicting a Poor Outcome after a Stroke

By  

Neuroimmunomodulation, Vol. 22, Iss. 6, 2015-0 ,pp. : 365-372

Karger

Access to resources Recommend Favorite

Concentration of Soluble Adhesion Molecules (sVCAM-1, sICAM-1 and sL-Selectin) in the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis and Systemic Lupus erythematosus with Central Nervous Involvement

By  

Neuroimmunomodulation, Vol. 9, Iss. 1, 2001-06 ,pp. : 49-54

Karger

Access to resources Recommend Favorite